Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


01.01.2018

3 Am J Clin Oncol
1 Am J Surg
4 Ann Oncol
9 Ann Surg
7 Anticancer Res
4 BMC Cancer
1 BMC Gastroenterol
2 Br J Cancer
1 Br J Surg
2 Cancer
1 Cancer Lett
1 Clin Cancer Res
1 Eur J Cancer
1 Eur J Surg Oncol
2 Gut
3 Int J Cancer
1 Int J Colorectal Dis
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Surg Oncol
2 Lancet Gastroenterol Hepatol
1 Lancet Oncol
1 Lancet Public Health
1 Oncogene
5 Oncology
6 PLoS One
1 Proc Natl Acad Sci U S A
1 Semin Oncol
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. LAURENT M, Des Guetz G, Bastuji-Garin S, Culine S, et al
    Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
    Am J Clin Oncol. 2018;41:73-80.
    PubMed     Text format     Abstract available

  2. SHANKARAN V, Ortendahl JD, Purdum AG, Bolinder B, et al
    Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.
    Am J Clin Oncol. 2018;41:65-72.
    PubMed     Text format     Abstract available

  3. QIU H, Katz AW, Chowdhry AK, Usuki KY, et al
    Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Am J Clin Oncol. 2018;41:53-58.
    PubMed     Text format     Abstract available


    Am J Surg

  4. LABGAA I, Slankamenac K, Schadde E, Jibara G, et al
    Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Am J Surg. 2018;215:125-130.
    PubMed     Text format     Abstract available


    Ann Oncol

  5. ROMBOUTS AJM, Hugen N, Elferink MAG, Feuth T, et al
    Incidence of second tumors after treatment with or without radiation for rectal cancer.
    Ann Oncol. 2017;28:535-540.
    PubMed     Text format     Abstract available

  6. YANG TO, Cairns BJ, Reeves GK, Green J, et al
    Cancer risk among 21st century blood transfusion recipients.
    Ann Oncol. 2017;28:393-399.
    PubMed     Text format     Abstract available

  7. PATEL UB, Brown G, Machado I, Santos-Cores J, et al
    MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.
    Ann Oncol. 2017;28:344-353.
    PubMed     Text format     Abstract available

  8. GONG J, Tian J, Lou J, Wang X, et al
    A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with a MYC regulated SNP rs6983267.
    Ann Oncol. 2017 Dec 18. pii: 4756051. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg

  9. CHI P, Chen Z, Lu X
    Transanal Total Mesorectal Excision: Can it Achieve the Standard of TME?
    Ann Surg. 2017;266:e87-e88.
    PubMed     Text format    

  10. BATTERSBY NJ, Moran B, Stelzner S, West NP, et al
    Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
    Ann Surg. 2017;266:e116-e118.
    PubMed     Text format    

  11. SASAKI K, Morioka D, Conci S, Margonis GA, et al
    The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
    Ann Surg. 2018;267:132-141.
    PubMed     Text format     Abstract available

  12. RUI YY, Zhou ZG, Wang C, Yang L, et al
    Are We Ready for Extralevatory Abdominoperineal Excision?
    Ann Surg. 2017;265:e55-e56.
    PubMed     Text format    

  13. SAMMOUR T, Chang GJ
    Lateral Node Dissection in Low Rectal Cancer: Time for a Global Approach?
    Ann Surg. 2017;266:208-209.
    PubMed     Text format    

  14. MONSON JRT, Arsalanizadeh R
    Transanal Total Mesorectal Excision (TaTME) and Quality of Rectal Cancer Surgery: Do we Really Know?
    Ann Surg. 2017;266:e88-e89.
    PubMed     Text format    

  15. EVRARD S, Poston G
    Response to Faitot et al "Two-stage Hepatectomy Versus 1-Stage Resection Combined With Radiofrequency for Bilobar Colorectal Metastases: A Case-matched Analysis of Surgical and Oncological Outcomes".
    Ann Surg. 2017;265:e52-e53.
    PubMed     Text format    

  16. CHEN WH, Luo SL, Kang L
    Transanal Total Mesorectal Excision: Will It Be A Valid Alternative in Rectal Cancer Surgery?
    Ann Surg. 2017;265:e36-e37.
    PubMed     Text format    

  17. SMITH FM, Rooney P, Farrell C
    Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
    Ann Surg. 2017;266:e104-e105.
    PubMed     Text format    


    Anticancer Res

  18. KATSUKI T, Nakayama Y, Akiyama M, Sawatsubashi Y, et al
    Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
    Anticancer Res. 2018;38:569-575.
    PubMed     Text format     Abstract available

  19. MIYAMOTO Y, Oki E, Emi Y, Tokunaga S, et al
    Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.
    Anticancer Res. 2018;38:491-499.
    PubMed     Text format     Abstract available

  20. MURONO K, Kawai K, Hata K, Emoto S, et al
    Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
    Anticancer Res. 2018;38:15-22.
    PubMed     Text format     Abstract available

  21. YANG G, Qiu J, Wang D, Tao Y, et al
    Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.
    Anticancer Res. 2018;38:131-136.
    PubMed     Text format     Abstract available

  22. JO YK, Park NY, Shin JH, Jo DS, et al
    Up-regulation of UVRAG by HDAC1 Inhibition Attenuates 5FU-induced Cell Death in HCT116 Colorectal Cancer Cells.
    Anticancer Res. 2018;38:271-277.
    PubMed     Text format     Abstract available

  23. SHAMOUN L, Kolodziej B, Andersson RE, Dimberg J, et al
    Protein Expression and Genetic Variation of IL32 and Association with Colorectal Cancer in Swedish Patients.
    Anticancer Res. 2018;38:321-328.
    PubMed     Text format     Abstract available

  24. TAKAHASHI H, Haraguchi N, Nishimura J, Hata T, et al
    The Severity of Anastomotic Leakage May Negatively Impact the Long-term Prognosis of Colorectal Cancer.
    Anticancer Res. 2018;38:533-539.
    PubMed     Text format     Abstract available


    BMC Cancer

  25. SONG N, Shin A, Jung HS, Oh JH, et al
    Effects of interactions between common genetic variants and smoking on colorectal cancer.
    BMC Cancer. 2017;17:869.
    PubMed     Text format     Abstract available

  26. ZHANG K, Wang Y, Yu X, Shi Y, et al
    Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
    BMC Cancer. 2017;17:899.
    PubMed     Text format     Abstract available

  27. FALKOWSKI S, Woillard JB, Postil D, Tubiana-Mathieu N, et al
    Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
    BMC Cancer. 2017;17:901.
    PubMed     Text format     Abstract available

  28. SHIN HY, Suh M, Park B, Jun JK, et al
    Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea.
    BMC Cancer. 2017;17:860.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  29. ESTEBAN S, Ricci R, Terrasa S, Kopitowski K, et al
    Colonoscopy overuse in colorectal cancer screening and associated factors in Argentina: a retrospective cohort study.
    BMC Gastroenterol. 2017;17:162.
    PubMed     Text format     Abstract available


    Br J Cancer

  30. ALBUQUERQUE A, Pessegueiro Miranda H, Lopes J, Gandara J, et al
    Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions.
    Br J Cancer. 2017;117:1761-1767.
    PubMed     Text format     Abstract available

  31. LIEVRE A, Ouine B, Canet J, Cartier A, et al
    Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.
    Br J Cancer. 2017;117:1819-1827.
    PubMed     Text format     Abstract available


    Br J Surg

  32. ESCAL L, Nougaret S, Guiu B, Bertrand MM, et al
    MRI-based score to predict surgical difficulty in patients with rectal cancer.
    Br J Surg. 2018;105:140-146.
    PubMed     Text format     Abstract available


    Cancer

  33. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available

  34. PRINTZ C
    Study finds link between inflammation and colorectal cancer.
    Cancer. 2018;124:13.
    PubMed     Text format    


    Cancer Lett

  35. KIM CW, Oh ET, Kim JM, Park JS, et al
    Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
    Cancer Lett. 2017;416:31-41.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  36. DIENSTMANN R
    Tumor side as model of integrative molecular classification of colorectal cancer.
    Clin Cancer Res. 2017 Dec 21. pii: 1078-0432.CCR-17-3477.
    PubMed     Text format     Abstract available


    Eur J Cancer

  37. VAN CUTSEM E, Mayer RJ, Laurent S, Winkler R, et al
    The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer.
    Eur J Cancer. 2017;90:63-72.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  38. VAN EDEN WJ, Kok NFM, Woensdregt K, Huitema ADR, et al
    Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
    Eur J Surg Oncol. 2017 Nov 15. pii: S0748-7983(17)30956.
    PubMed     Text format     Abstract available


    Gut

  39. DEMING DA
    Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Gut. 2017 Dec 21. pii: gutjnl-2017-315394. doi: 10.1136/gutjnl-2017-315394.
    PubMed     Text format    

  40. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Text format     Abstract available


    Int J Cancer

  41. JI J, Sundquist J, Sundquist K
    Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Int J Cancer. 2017 Dec 22. doi: 10.1002/ijc.31228.
    PubMed     Text format     Abstract available

  42. LIU W, Wang S, Sun Q, Yang Z, et al
    DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-kappaB Pathway in Colorectal Cancer.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31232.
    PubMed     Text format     Abstract available

  43. GIES A, Bhardwaj M, Stock C, Schrotz-King P, et al
    Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31233.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  44. FRANSGAARD T, Thygesen LC, Gogenur I
    Statin use is not associated with improved 30-day survival in patients undergoing surgery for colorectal cancer.
    Int J Colorectal Dis. 2017 Dec 21. pii: 10.1007/s00384-017-2947.
    PubMed     Text format     Abstract available


    J Clin Oncol

  45. BUTOW PN, Turner J, Gilchrist J, Sharpe L, et al
    Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
    J Clin Oncol. 2017;35:4066-4077.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  46. SJOQUIST KM, Renfro LA, Simes RJ, Tebbutt NC, et al
    Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
    J Natl Cancer Inst. 2017 Dec 18. pii: 4757465. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  47. KOZMAN MA, Fisher OM, Rebolledo BJ, Parikh R, et al
    CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24911.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  48. ADAMS R, Brown E, Brown L, Butler R, et al
    Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.
    Lancet Gastroenterol Hepatol. 2017 Dec 15. pii: S2468-1253(17)30394.
    PubMed     Text format     Abstract available

  49. SCHMOLL HJ
    FOCUS4: a new trial design for evaluation of targeted drugs in colorectal cancer?
    Lancet Gastroenterol Hepatol. 2017 Dec 15. pii: S2468-1253(17)30402.
    PubMed     Text format    


    Lancet Oncol

  50. BURKI TK
    TAS-102 in metastatic colorectal cancer.
    Lancet Oncol. 2017 Dec 14. pii: S1470-2045(17)30927.
    PubMed     Text format    


    Lancet Public Health

  51. KUIPERS EJ, Lansdorp-Vogelaar I
    Colorectal cancer screening in Australia.
    Lancet Public Health. 2017;2:e304-e305.
    PubMed     Text format    


    Oncogene

  52. LEE SH, Yu J, Hwang GH, Kim S, et al
    CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR.
    Oncogene. 2017;36:6823-6829.
    PubMed     Text format     Abstract available


    Oncology

  53. YAMADA M, Sakurai T, Komeda Y, Nagai T, et al
    Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease.
    Oncology. 2017;93 Suppl 1:20-26.
    PubMed     Text format     Abstract available

  54. OGAWA S, Ishii T, Minaga K, Nakatani Y, et al
    The Feasibility of 18-mm-Diameter Colonic Stents for Obstructive Colorectal Cancers.
    Oncology. 2017;93 Suppl 1:43-48.
    PubMed     Text format     Abstract available

  55. OKAMOTO K, Watanabe T, Komeda Y, Kono T, et al
    Risk Factors for Postoperative Bleeding in Endoscopic Submucosal Dissection of Colorectal Tumors.
    Oncology. 2017;93 Suppl 1:35-42.
    PubMed     Text format     Abstract available

  56. KOMEDA Y, Kashida H, Sakurai T, Asakuma Y, et al
    Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) Classification.
    Oncology. 2017;93 Suppl 1:49-54.
    PubMed     Text format     Abstract available

  57. SAKURAI T, Adachi T, Kono M, Arizumi T, et al
    Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant Therapy.
    Oncology. 2017;93 Suppl 1:27-29.
    PubMed     Text format     Abstract available


    PLoS One

  58. SERRANO-VILLAR S, Hernandez-Novoa B, de Benito A, Del Romero J, et al
    Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.
    PLoS One. 2017;12:e0188851.
    PubMed     Text format     Abstract available

  59. VIRGONE-CARLOTTA A, Lemasson M, Mertani HC, Diaz JJ, et al
    In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.
    PLoS One. 2017;12:e0188100.
    PubMed     Text format     Abstract available

  60. HOEDJES M, de Kruif A, Mols F, Bours M, et al
    An exploration of needs and preferences for dietary support in colorectal cancer survivors: A mixed-methods study.
    PLoS One. 2017;12:e0189178.
    PubMed     Text format     Abstract available

  61. ANANTHARAJU PG, Reddy DB, Padukudru MA, Chitturi CMK, et al
    Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC).
    PLoS One. 2017;12:e0186208.
    PubMed     Text format     Abstract available

  62. GRAF JF, Zavodszky MI
    Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures.
    PLoS One. 2017;12:e0188878.
    PubMed     Text format     Abstract available

  63. MA L, Wang L, Shan Y, Nafees M, et al
    Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.
    PLoS One. 2017;12:e0188665.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  64. AYMERIC L, Donnadieu F, Mulet C, du Merle L, et al
    Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization.
    Proc Natl Acad Sci U S A. 2017 Dec 26. pii: 1715112115.
    PubMed     Text format     Abstract available


    Semin Oncol

  65. BAS Y, Hassan HA, Adiguzel C, Bulur O, et al
    The distribution of cancer cases in Somalia.
    Semin Oncol. 2017;44:178-186.
    PubMed     Text format     Abstract available


    World J Surg

  66. JUNG SM, Hong YS, Kim TW, Park JH, et al
    Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer.
    World J Surg. 2017 Dec 27. pii: 10.1007/s00268-017-4409.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: